FReSH-32715-en
new study to translate in french
-Adult patient defined as a confirmed case of COVID-19 who has been hospitalized or not for COVID-19 -Date of onset of first symptoms of COVID-19 ≥ 4 weeks and < 4 months
-Patients with functional and/or respiratory impairment and/or asthenia and/or malnutrition persisting beyond 4 weeks after the onset of COVID-19 symptoms: o Increase in mMRC dyspnea score ≥ 1 between the month preceding COVID-19 and beyond the first 4 weeks post-COVID-19 and/or
o Asthenia score > 22 on the Pichot scale beyond the first 4 weeks post-COVID-19, in the absence of asthenia present in the month preceding COVID-19 (asthenia score on the Pichot scale <8) and/or
o Reported weight loss > 5% in less than 6 months, comparing the patient's minimum weight in the month preceding COVID-19 and their weight beyond the first 4 weeks post-COVID-19 and/or
o Current BMI < 20 (if age < 70 years) or < 22 (if age ≥ 70 years) if BMI was ≥ 20 (if age < 70 years) or ≥ 22 (if age ≥ 70 years) in the month preceding COVID-19
Individus
| Topic | Vocabulary |
|---|---|
| Diabetes mellitus due to drug or chemical | cim-11 |
| Diabetes mellitus | cim-11 |
| Oncovirus | cim-11 |
| Behavioral determinants | health determinant |
{
"level_sex_clusion_I": [],
"level_age_clusion_I": [],
"level_type_clusion_I": "",
"level_type_clusion_other": "",
"clusion_I": "",
"clusion_E": ""
}
| Name |
|---|
| ; |
['Through independent healthcare practitioners']
['{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability"},"value":"Non-probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability.Quota"},"value":"Non-probability: Quota"}']
every day
FReSH-32715-en
| Name |
|---|
| Alessandro Morichetta |